The AMP framework significantly influence the pharmaceutical market and the potential to provide patients with a wider scope of essential medicines while effectively manage government and patients' healthcare spending. There is a need for the AMP re-evaluation tool enabling timely diagnosing of its shortcomings, assessing the effectiveness and helping to implement its targeted development according to pharmaceutical market tendencies and achievement of desirable patient's health outcomes.